ClinicalTrials.Veeva

Menu

Breathing Exercise in Pregnancy-induced Hypertension

R

Riphah International University

Status

Completed

Conditions

Pregnancy Induced Hypertension

Treatments

Other: Group B
Other: Group A

Study type

Interventional

Funder types

Other

Identifiers

NCT05828615
Rec/01385 Rida Kanwal

Details and patient eligibility

About

To determine the effects of Breathing control vs Alternate nostril breathing on maternal cardiovascular parameters in pregnancy and to determine the effect of breathing control vs Alternate nostril breathing on Fetal Heart rate. Many evidence-based studies show breathing exercises have beneficial and useful effects on the hypertensive population and also have positive effects on pregnancy-induced hypertension.

Full description

Many breathing interventions are used for pregnancy-induced hypertension but the comparison is limited between two breathing techniques. In this study, a comparison will be carried out between evidence-based breathing techniques including breathing control and alternate nostril breathing to see which of these two exercises gives the best effects on females with pregnancy-induced hypertension.

Enrollment

46 patients

Sex

Female

Ages

20 to 35 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Females with 3rd-trimester pregnancies included
  • BMI<3
  • Diagnosed pregnancy-induced HTN

Exclusion criteria

  • An exaggerated response to exercise on BP ( 160/110 mmHg )
  • Uncontrolled Diabetics or asthma
  • Cardiac diseases
  • Orthopedic complications
  • Using anti-epileptic drugs and
  • Hyperthyroidism or hypothyroidism

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

46 participants in 2 patient groups

Group A
Active Comparator group
Description:
Alternate nostril breathing exercise 2 times a day, 10 min duration of exercise each time, for 5 days
Treatment:
Other: Group A
Group B
Active Comparator group
Description:
Breathing control exercise 2 times a day, 10 min duration of exercise each time, for 5 days
Treatment:
Other: Group B

Trial contacts and locations

1

Loading...

Central trial contact

Mehwish Waseem, MSPT(CPPT)

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems